A new Russian medicine being used on Covid-19 patients has reduced the mortality rate by up to five times, according to its developer, Oleg Rosenberg, of Surfactant-BL. The drug is most commonly used to treat severe lung lesions. … Read More >Another breakthrough? New Russian drug means fewer Covid-19 patients need ventilators, has significantly reduced mortality